iCAD finds partner for CT (computed tomography) lung CAD in development:
This article was originally published in Clinica
Viatronix has agreed to distribute iCAD's new tool to help radiologists identify cancerous and precancerous lung nodules in computed tomography (CT) images. The technology is still in development and has yet to be approved by the FDA. Stony Brook, New York-based Viatronix sells 3D CT visualisation software. iCAD, of Nashua, New Hampshire, recently agreed to make film-based CAD mammography systems for partner Hologic to sell to clinics with low case volumes. The roll-out of the Second Look 200 system for low-volume practices drove third-quarter sales of $6m, compared with $1.6m a year earlier.
You may also be interested in...
Deal Snapshot: AstraZeneca has sublicensed global rights to its peripheral mu-opioid receptor antagonist to RedHill Biopharma, excluding Europe, Canada and Israel, with RedHill also separately receiving non-dilutive financing from HealthCare Royalty Partners.
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.